Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria

Published:2012-08-29 Issue:3 Volume:27 Page:e363-e369
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:

Author:

Magerl M.,Rother M.,Bieber T.,Biedermann T.,Brasch J.,Dominicus R.,Hunzelmann N.,Jakob T.,Mahler V.,Popp G.,Schäkel K.,Schlingensiepen R.,Schmitt J.,Siebenhaar F.,Simon J.C.,Staubach P.,Wedi B.,Weidner C.,Maurer M.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2012.04689.x/fullpdf

Reference22 articles.

1. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses;Zuberbier;J Eur Acad Dermatol Venereol,2012

2. Inflammatory mediators in allergic rhinitis;Gelfand;J Allergy Clin Immunol,2004

3. Autoreactive urticaria and autoimmune urticaria;Maurer;Hautarzt,2004

4. Mast cells: makers and breakers of allergic inflammation;Hakim-Rad;Curr Opin Allergy Clin Immunol,2009

5. Antihistamines in the treatment of urticaria;Zuberbier;Adv Exp Med Biol,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials;Clinical Drug Investigation;2024-09-06

2. Prise en charge de l’urticaire chronique spontanée : recommandations françaises;Annales de Dermatologie et de Vénéréologie - FMC;2023-03

3. Efficacy and safety of medications for antihistamine-refractory chronic spontaneous urticaria: a systematic review and network meta-analysis;Allergo Journal International;2022-12-21

4. Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives;Pharmaceuticals;2022-10-10

5. Impact of Pharmacological Treatments for Chronic Spontaneous Urticaria with an Inadequate Response to H1-Antihistamines on Health-Related Quality of Life: A Systematic Review and Network Meta-Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2022-01